PDF(Pubmed)
Abstract：
UNASSIGNED: The purpose of this study is to identify existing literature on recurrent atypical mycobacterial cervicofacial lymphadenitis to augment our understanding of a unique patient who presented to our tertiary-care center 5-years posttreatment with recurrence following curettage.
UNASSIGNED: OVID Medline, Scopus, and Web of Science.
UNASSIGNED: A literature search was conducted yielding 49 original articles which were screened twice by two independent reviewers resulting in 14 studies meeting inclusion criteria for data extraction using Covidence software. Two independent reviewers extracted data on recurrence of atypical mycobacterial cervicofacial lymphadenitis and consensus was reached on data points from all included studies.
UNASSIGNED: This study illuminated the paucity of recurrence reporting in the literature regarding atypical mycobacterial lymphadenitis. Sixteen studies identified in our review included discussions on recurrence with few elaborating beyond the rate of recurrence to describe their management. Fourteen out of sixteen studies provided recurrence rates for their cohort, 11 out of 14 specified the initial treatment modality, and only five out of eight studies that described initial treatment with surgery differentiated recurrence rates between complete and incomplete excision. The mean length of follow-up in the included studies was 20 months. There was one previously reported case of late recurrence at 5-years.
UNASSIGNED: We identified few reports that discussed the management of recurrence of atypical mycobacterial cervicofacial lymphadenitis. There was minimal data on recurrence rates between surgical treatment modalities. The case discussed in our study showcases that treatment with curettage has the potential to present with late recurrence.
UNASSIGNED: OVID Medline, Scopus, and Web of Science.
UNASSIGNED: A literature search was conducted yielding 49 original articles which were screened twice by two independent reviewers resulting in 14 studies meeting inclusion criteria for data extraction using Covidence software. Two independent reviewers extracted data on recurrence of atypical mycobacterial cervicofacial lymphadenitis and consensus was reached on data points from all included studies.
UNASSIGNED: This study illuminated the paucity of recurrence reporting in the literature regarding atypical mycobacterial lymphadenitis. Sixteen studies identified in our review included discussions on recurrence with few elaborating beyond the rate of recurrence to describe their management. Fourteen out of sixteen studies provided recurrence rates for their cohort, 11 out of 14 specified the initial treatment modality, and only five out of eight studies that described initial treatment with surgery differentiated recurrence rates between complete and incomplete excision. The mean length of follow-up in the included studies was 20 months. There was one previously reported case of late recurrence at 5-years.
UNASSIGNED: We identified few reports that discussed the management of recurrence of atypical mycobacterial cervicofacial lymphadenitis. There was minimal data on recurrence rates between surgical treatment modalities. The case discussed in our study showcases that treatment with curettage has the potential to present with late recurrence.
摘要：
■本研究的目的是确定有关复发性非典型分枝杆菌颈面部淋巴结炎的现有文献，以增强我们对一位特殊患者的认识，该患者在治疗5年后出现刮宫复发，并出现在我们的三级护理中心。
■OVIDMedline，Scopus,和WebofScience。
■进行了文献检索，产生了49篇原创文章，由两名独立评审员进行了两次筛选，结果有14项研究符合Covidence软件数据提取的纳入标准。两名独立评审员提取了非典型分枝杆菌颈面部淋巴结炎复发的数据，并就所有纳入研究的数据点达成共识。
■本研究揭示了关于非典型分枝杆菌淋巴结炎的文献中很少有复发报告。在我们的审查中确定的16项研究包括关于复发的讨论，除了复发率之外，很少详细说明它们的管理。16项研究中有14项提供了其队列的复发率，14个中有11个指定了初始治疗方式，8项研究中只有5项描述了手术的初始治疗，将完全切除和不完全切除的复发率区分开来。纳入研究的平均随访时间为20个月。以前曾报道过一例5年晚期复发病例。
■我们发现很少有关于非典型分枝杆菌颈面部淋巴结炎复发处理的报告。关于手术治疗方式之间复发率的数据很少。我们研究中讨论的病例表明，刮宫治疗有可能出现晚期复发。
■OVIDMedline，Scopus,和WebofScience。
■进行了文献检索，产生了49篇原创文章，由两名独立评审员进行了两次筛选，结果有14项研究符合Covidence软件数据提取的纳入标准。两名独立评审员提取了非典型分枝杆菌颈面部淋巴结炎复发的数据，并就所有纳入研究的数据点达成共识。
■本研究揭示了关于非典型分枝杆菌淋巴结炎的文献中很少有复发报告。在我们的审查中确定的16项研究包括关于复发的讨论，除了复发率之外，很少详细说明它们的管理。16项研究中有14项提供了其队列的复发率，14个中有11个指定了初始治疗方式，8项研究中只有5项描述了手术的初始治疗，将完全切除和不完全切除的复发率区分开来。纳入研究的平均随访时间为20个月。以前曾报道过一例5年晚期复发病例。
■我们发现很少有关于非典型分枝杆菌颈面部淋巴结炎复发处理的报告。关于手术治疗方式之间复发率的数据很少。我们研究中讨论的病例表明，刮宫治疗有可能出现晚期复发。
